GSK plc Noncurrent Financial Liabilities At Fair Value Through Profit Or Loss
GSK plc (GLAXF) had Noncurrent Financial Liabilities At Fair Value Through Profit Or Loss of GBP 5.38 billion as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss · last filed 2026-03-06
- 2025-12-31: Noncurrent Financial Liabilities At Fair Value Through Profit Or Loss 5.38B GBP.
- 2024-12-31: Noncurrent Financial Liabilities At Fair Value Through Profit Or Loss 6.11B GBP.
- 2023-12-31: Noncurrent Financial Liabilities At Fair Value Through Profit Or Loss 5.61B GBP.
| Period end | Noncurrent Financial Liabilities At Fair Value Through Profit Or Loss |
|---|---|
| 2025-12-31 | 5.38B GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 6.11B GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 5.61B GBP 20-F · filed 2025-03-03 |